Mersana Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
17.80
|
|
Average Rating
|
4.71
|
|
# Strong Buys
|
6
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.09
|
-0.61
|
-0.52
|
-577.78%
|
|
2022-06-30
|
-0.52
|
-0.55
|
-0.03
|
-5.77%
|
|
2022-03-31
|
-0.32
|
-0.59
|
-0.27
|
-84.38%
|
|
2021-12-31
|
-0.67
|
-0.68
|
-0.01
|
-1.49%
|
|
2021-09-30
|
-0.58
|
-0.63
|
-0.05
|
-8.62%
|
|
2021-06-30
|
-0.50
|
-0.59
|
-0.09
|
-18.00%
|
|
2021-03-31
|
-0.39
|
-0.50
|
-0.11
|
-28.21%
|
|
2020-12-31
|
-0.32
|
-0.42
|
-0.10
|
-31.25%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.75
|
|
2021-12-31
|
-2.40
|
|
2020-12-31
|
-1.43
|
|
2019-12-31
|
-0.35
|
|
2018-12-31
|
-2.80
|
|
2017-12-31
|
-13.31
|